Could a Drug Slinger Become The US President?

Could this Indian drug slinger become the next US president?

Vivek Ramaswamy wants to dismantle the FBI and claims to be the anti-woke champion within business.

In 2014 he founded Roivant Sciences, completely flipping the script on Big Pharma.

Cleverly, he didn't aim to create new drugs; instead, he bought failed late-stage drug candidates. Why? Vivek saw an untapped goldmine.

With $100 mill from Bermuda-based capital, Big Viv’s approach massively cut R&D costs and fast-tracked the commercialization process.

And in 2015, his subsidiary, Axovant, bought a flunked Alzheimer's drug from GlaxoSmithKline for just $5 million.

But this was the clincher: Big Viv boldly declared on Forbes Magazine that Axovant would achieve the "highest ROI in pharma history," and investors listened.

Axovant's market value ballooned to nearly $3 billion. But then, out of nowhere, Vivek cashed out over $37 million, raising eyebrows.

Then came the bombshell - the drug failed in final trials, Axovant's value crashed by 75%, and the company dissolved. But Big Viv walked away, unscathed.

Big Viv is making undeniable waves among the Republican Party in the presidential race.. but is his run for the White House authentic? Or is it a PR stunt aimed to convince the public he can revive a struggling country?